BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, January 20, 2026
Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

Novacea’s IPO Seeks $75M To Fund Late-Stage DN-101

Feb. 14, 2006
By Aaron Lorenzo

Black Box Warning Labels To Remain On All NSAIDs

Feb. 13, 2006
By Aaron Lorenzo

Acorda’s Second Attempt At IPO Successful: $33M

Feb. 13, 2006
By Aaron Lorenzo
Acorda Therapeutics Inc. priced a $33 million initial public offering Friday, selling 5.5 million common shares at $6 apiece. (BioWorld Today)
Read More

Acorda’s Second Attempt At IPO Successful: $33M

Feb. 13, 2006
By Aaron Lorenzo
Acorda Therapeutics Inc. priced a $33 million initial public offering Friday, selling 5.5 million common shares at $6 apiece. (BioWorld Today)
Read More

Black Box Warning Labels To Remain On All NSAIDs

Feb. 13, 2006
By Aaron Lorenzo

Entereg’s Positive Phase III Data Drive Up Adolor’s Stock

Feb. 9, 2006
By Aaron Lorenzo
Adolor Corp. unveiled positive Phase III data on Entereg (alvimopan), its partnered product for postoperative ileus, boosting shares in the company. (BioWorld Today)
Read More

Entereg’s Positive Phase III Data Drive Up Adolor’s Stock

Feb. 9, 2006
By Aaron Lorenzo
Adolor Corp. unveiled positive Phase III data on Entereg (alvimopan), its partnered product for postoperative ileus, boosting shares in the company. (BioWorld Today)
Read More

Vertex Reports Data On HCV Protease Inhibitor, Earnings

Feb. 8, 2006
By Aaron Lorenzo
Hepatitis C viral loads dropped to undetectable levels in all patients receiving for about a month an investigational drug from Vertex Pharmaceuticals Inc. (BioWorld Today)
Read More

Vertex Reports Data On HCV Protease Inhibitor, Earnings

Feb. 8, 2006
By Aaron Lorenzo
Hepatitis C viral loads dropped to undetectable levels in all patients receiving for about a month an investigational drug from Vertex Pharmaceuticals Inc. (BioWorld Today)
Read More

Bush's Proposed Budget Boosts FDA Funds In '07

Feb. 7, 2006
By Aaron Lorenzo
View All Articles by Aaron Lorenzo

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing